Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-053125

CEO & President bought 20,000 shares at $0.13 ($2,680)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K · CEO & President

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Purchase : show line 1 in the form +20,000 $0.13 $2,680 386,095 D
Open-market purchases · 20,000 sh · avg $0.13 · $2,680
Loading xslF345X06/ownership.xml…